Gutscheinbedingungen

**Gültig vom 07.09.2026 bis 09.09.2026 | Gültig für nicht preisgebundene fremdsprachige Bücher | Einzelne Artikel können ausgeschlossen sein | Online auf www.bücher.de einlösbar | Click & Collect nur mit Online-Zahlung (Paypal/Kreditkarte) vorab | Nicht kombinierbar mit anderen Gutscheinen oder Preisaktionen | Nur einmal pro Einkauf einlösbar | Gutschein wird auf max. 500€ Bestellwert angerechnet | Keine Barauszahlung | Nicht gültig für Versandkosten und Services

  • Produktbild: Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19
  • Produktbild: Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19
Band 1412 - 12%

Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19

12% sparen

139,99 € UVP 160,49 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

29.06.2023

Abbildungen

XI, 513 p. 87 illus., 74 illus. in color.

Herausgeber

Paul C. Guest

Verlag

Springer

Seitenzahl

513

Maße (L/B/H)

24,1/16/3,4 cm

Gewicht

951 g

Auflage

23001 Auflage 1st edition 2023

Sprache

Englisch

ISBN

978-3-031-28011-5

Beschreibung

Portrait


Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 38 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He is also affiliated with the University of Campinas in Sao Paulo Brazil and Otto-von-Guericke-University in Magdeburg Germany, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia, age-related diseases such as diabetes, cancer, cardiovascular disorders, sarcopenia and Alzheimer’s disease, and more recently on infectious diseases such as COVID-19. 

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

29.06.2023

Abbildungen

XI, 513 p. 87 illus., 74 illus. in color.

Herausgeber

Paul C. Guest

Verlag

Springer

Seitenzahl

513

Maße (L/B/H)

24,1/16/3,4 cm

Gewicht

951 g

Auflage

23001 Auflage 1st edition 2023

Sprache

Englisch

ISBN

978-3-031-28011-5

Herstelleradresse

Springer-Verlag GmbH
Tiergartenstr. 17
69121 Heidelberg
DE

Email: ProductSafety@springernature.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19
  • Produktbild: Application of Omic Techniques to Identify New Biomarkers and Drug Targets for COVID-19
  • Chapter 1. The COVID-19 Pandemic: SARS-CoV-2 Structure, Infection, Transmission, Symptomology and Variants of Concern.- Chapter 2. Long-term Vaccination and Treatment Strategies for COVID-19 Disease and Future Coronavirus Pandemics.- Chapter 3. Consequences of the Lockdown - Domestic Violence during the COVID-19 Pandemic.- Chapter 4. Psychological distress impact of Coronavirus disease (COVID-19) outbreak on three continents: A systematic review and meta-analysis.- Chapter 5. A Molecular Biomarker-based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms.- Chapter 6. Genetic Associations with Coronavirus Susceptibility and Disease Severity.- Chapter 7. COVID Diagnostics: from Molecules to Omics.- Chapter 8. Assessing Biomarkers in Viral Infection.- Chapter 9. Proteomic Investigation of COVID-19 Severity During the Tsunamis Second Wave in Mumbai.- Chapter 10. NMR-Metabolomics in COVID-19 Research.- Chapter 11. Potential Biomarkers of Mitochondrial Dysfunction Associated with COVID-19 Infection.- Chapter 12. Red Cell Distribution Width as a Prognostic Indicator for Mortality and ICU Admission in Patients with COVID-19.- Chapter 13. Predicting the COVID-19 Patients Status using Chest CT Scan Findings: A Risk Assessment Model Based on Decision Tree Analysis.- Chapter 14. Inferring Recombination Events in SARS-CoV-2 Variants In Silico.- Chapter 15. Amplicon-based Nanopore Sequencing of Patients Infected by the SARS-CoV-2 Omicron (B.1.1.529) Variant in India.- Chapter 16. Perspectives on Rapid Antigen Tests for Downstream Validation and Development of Theranostics.- Chapter 17. Machine Learning and COVID-19: Lessons from SARS-CoV-2.- Chapter 18. The Relationship between Psoriasis, COVID-19 Infection and Vaccination during Treatment of Patients.- Chapter 19. Immunogenicity of Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV; Sinopharm) and Short-term Clinical Outcomes in Vaccinated Solid Organ Transplant Recipients: A Prospective Cohort Study.- Chapter 20. Spices and Biomarkers of COVID-19: A Mechanistic and Therapeutic Perspective.- Chapter 21. Antiviral Mechanisms of Curcumin and its Derivatives in Prevention and Treatment of COVID-19: A review.- Chapter 22. Evaluation of Curcumin-Piperine Supplementation in COVID-19 Patients Admitted to the Intensive Care: A Double-Blind, Randomized Controlled Trial.- Chapter 23. Chronobiological Efficacy of Combined Therapy of Pelargonium Sidoides and Melatonin in Acute and Persistent Cases of COVID-19: A Hypothetical Approach.- Chapter 24. The Potential Effect of Royal Jelly on Biomarkers Related to COVID-19 Infection and Severe Progression.- Chapter 25. Statins: Beneficial Effects in Treatment of COVID-19.- Chapter 26. Multiplex Immunoassay Approaches Using Luminex® xMAP® Technology for the Study of COVID-19 Disease.- Chapter 27. Rapid Detection of SARS-CoV-2 Variants of Concern by Genomic Surveillance Techniques.